Close

Celyad SA (CYAD) Announces Presentation of Encouraging NKR-2 Phase I Data at ASH 2016

November 7, 2016 8:53 AM EST Send to a Friend
Celyad (Nasdaq: CYAD) announces that first data analysis of the NKR-2 Phase I trial shows encouraging results which will be ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login